Scott Tarriff

2018

In 2018, Scott Tarriff earned a total compensation of $11.3M as Chief Executive Officer, Director at Eagle Pharmaceuticals, a 41% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$654,000
Option Awards$4,199,835
Salary$769,410
Stock Awards$5,681,970
Other$19,241
Total$11,324,456

Tarriff received $5.7M in stock awards, accounting for 50% of the total pay in 2018.

Tarriff also received $654K in non-equity incentive plan, $4.2M in option awards, $769.4K in salary and $19.2K in other compensation.

Rankings

In 2018, Scott Tarriff's compensation ranked 565th out of 14,244 executives tracked by ExecPay. In other words, Tarriff earned more than 96.0% of executives.

ClassificationRankingPercentile
All
565
out of 14,244
96th
Division
Manufacturing
182
out of 5,765
97th
Major group
Chemicals And Allied Products
53
out of 2,128
98th
Industry group
Drugs
41
out of 1,817
98th
Industry
Pharmaceutical Preparations
29
out of 1,391
98th

Pay ratio

Scott Tarriff's Pay$11,324,456
Median Employee's Pay$236,618
Pay Ratio

48

to 1

In 2018, the annual total compensation of Scott Tarriff was $11,324,456.

The annual total compensation of the median employee at Eagle Pharmaceuticals was $236,618.

The ratio of Scott Tarriff's pay to the pay of median employee was therefore 48 to one.

Source: SEC filing on April 30, 2019.

Tarriff's colleagues

We found four more compensation records of executives who worked with Scott Tarriff at Eagle Pharmaceuticals in 2018.

2018

David Pernock

Eagle Pharmaceuticals

Chief Operating Officer

2018

Adrian Hepner

Eagle Pharmaceuticals

Chief Medical Officer

2018

Pete Meyers

Eagle Pharmaceuticals

Chief Financial Officer

2018

Steven Krill

Eagle Pharmaceuticals

Chief Scientific Officer

News

You may also like